A real-world pharmacovigilance analysis of adverse events associated with irbesartan using the FAERS and JADER databases

ObjectiveHypertension is a leading global risk factor for disability and death. Irbesartan, a potent angiotensin II receptor blocker, requires continuous safety monitoring. We conducted a disproportionality analysis of irbesartan-related adverse drug events (ADEs) using the FDA’s FAERS and Japan’s J...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Qian Liu, Zhiwei Cui, Chao Deng, Chao Yang, Tao Shi
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2024-11-01
Serie:	Frontiers in Pharmacology
Soggetti:	pharmacovigilance disproportionality analysis FAERS JADER irbesartan adverse drug events
Accesso online:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1485190/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!